Form 4: Medtronic SVP, Chief HR Officer Matthew R. Walter Reports Changes in Beneficial Ownership

Matthew R. Walter, SVP, Chief HR Officer of Medtronic plc, reports acquisition and disposal of ordinary shares and derivative securities.

Summary

• On July 29, 2024, Matthew R. Walter, SVP, Chief HR Officer of Medtronic plc, reported changes in beneficial ownership.
• Walter acquired 7,625 ordinary shares at $0 and disposed of 25,205 ordinary shares.
• He also acquired 19,063 performance share units (PSUs) which vest on July 29, 2027.
• The number of shares issued for PSUs depends on performance metrics over a three-year period; target performance yields 19,063 shares, maximum performance yields 38,126 shares, and failure to meet minimum performance results in 0 shares.
• Additionally, Walter acquired 56,364 stock options exercisable at $80, with 25% of the shares vesting annually starting on the first anniversary of the grant, expiring on July 29, 2034.
• Following these transactions, Walter directly owns 56,364 stock options and 19,063 performance share units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of transactions. The acquisition of shares and options is mildly positive, while the disposal of shares is mildly negative. Overall, it doesn't strongly indicate a positive or negative outlook.

Positives

• The acquisition of performance share units incentivizes the executive to achieve certain performance metrics over a three-year period.
• The vesting schedule of the stock options encourages long-term commitment from the executive.

Negatives

• The disposal of 25,205 ordinary shares could be interpreted negatively, although the reason for disposal is not specified.

Risks

• The value of the performance share units is contingent on achieving specific performance metrics, which may not be met.
• The stock options are exercisable at $80, which may be above the current market price, making them less valuable if the stock price does not increase.

Future Outlook

The number of shares to be issued in connection with the performance share units will vary depending on the level of certain performance metrics achieved over a three (3) year performance period.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely monitored by investors to gauge management's sentiment and confidence in the company's prospects.

Comparison to Industry Standards

• Executive compensation packages often include a mix of salary, stock options, and performance-based equity awards.
• Companies like Johnson & Johnson (JNJ) and Abbott Laboratories (ABT) also utilize similar compensation structures to align executive incentives with shareholder value.
• The vesting schedules and performance metrics associated with these awards are typically benchmarked against industry peers to ensure competitiveness.

Stakeholder Impact

• The transactions may have a minor impact on shareholders' perception of management's confidence in the company.
• Employees may view the executive's compensation package as a reflection of the company's commitment to its leadership.

Key Dates